for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Carlyle Group Inc

CG.O

Latest Trade

28.47USD

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

15.21

 - 

34.98

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
28.47
Open
--
Volume
--
3M AVG Volume
51.90
Today's High
--
Today's Low
--
52 Week High
34.98
52 Week Low
15.21
Shares Out (MIL)
348.36
Market Cap (MIL)
9,917.77
Forward P/E
18.36
Dividend (Yield %)
5.23

Next Event

Dividend For CG.OQ - 0.2500 USD

Latest Developments

More

Carlyle Group Reports Q2 Net Income Of $0.41 Per Share

Bharti Airtel Ltd Says Carlyle To Acquire Stake In Airtel's Data Centre Business

Carlyle Group To Acquire Majority Equity Interest In Envea

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Carlyle Group Inc

The Carlyle Group Inc., formerly The Carlyle Group L.P., is a diversified multi-product global alternative asset management firm. The Company advises on various investment funds and other investment vehicles that invests across a range of industries, geographies, asset classes and investment strategies, and seeks to deliver returns for its fund investors. The Company operates in four segments: Corporate Private Equity (CPE), Real Assets, Global Credit and Investment Solutions. The Corporate Private Equity segment is comprised of the operations that advise a diverse group of funds that invest in buyout, middle market and growth capital transactions that focus on either a geography or a particular industry. The Real Assets segment is comprised of the operations that advise United States and international funds focused on real estate, infrastructure, energy and renewable energy transactions.

Industry

Investment Services

Contact Info

C/O The Carlyle Group

1001 Pennsylvania Avenue, N.W.

WASHINGTON, DC

20004

United States

+1.202.7295626

https://www.carlyle.com

Executive Leadership

William E. Conway

Co-Executive Chairman of the Board, Founder

David M. Rubenstein

Founder, Co-Executive Chairman, Director

Daniel A. D' Aniello

Founder, Chairman Emeritus and Director

Kewsong Lee

Co-Chief Executive Officer, Director

Glenn A. Youngkin

Co-Chief Executive Officer, Director

Key Stats

2.60 mean rating - 15 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2017

3.4K

2018

2.2K

2019

2.1K

2020(E)

2.1K
EPS (USD)

2017

3.470

2018

5.560

2019

1.700

2020(E)

1.701
Price To Earnings (TTM)
260.95
Price To Sales (TTM)
6.42
Price To Book (MRQ)
5.32
Price To Cash Flow (TTM)
157.93
Total Debt To Equity (MRQ)
342.26
LT Debt To Equity (MRQ)
338.49
Return on Investment (TTM)
0.36
Return on Equity (TTM)
0.24

Latest News

Latest News

Carlyle's second-quarter earnings fall less than expected

Carlyle Group Inc <CG.O> reported a smaller-than-expected 7% year-on-year drop in second-quarter distributable earnings on Thursday, as profits in its private equity and credit divisions partly offset declines in real estate and energy businesses.

Lee to be sole Carlyle CEO as Youngkin steps down

Carlyle Group Inc <CG.O> said on Tuesday that Glenn Youngkin will step down as co-chief executive to dedicate himself to public service, leaving Kewsong Lee as sole CEO of one of the world's biggest private equity firms.

Carlyle buys 20% stake in Piramal Pharma businesses

U.S.-based Carlyle Group Inc has agreed to buy a 20% stake in the pharmaceutical unit of Indian conglomerate Piramal Enterprises Ltd for about $490 million, the companies said in a statement on Saturday.

Carlyle buys 20% stake in Piramal Pharma businesses

U.S.-based Carlyle Group Inc has agreed to buy a 20% stake in India's Piramal Enterprises Ltd's pharmaceutical businesses for about $490 million, the companies said in a statement on Saturday.

BRIEF-Carlyle And Piramal Pharma Sign Agreement On A 20% Strategic Growth Investment

* THE CARLYLE GROUP LP - CARLYLE AND PIRAMAL PHARMA SIGN AGREEMENT ON A 20% STRATEGIC GROWTH INVESTMENT

Carlyle-backed Ortho Clinical gets U.S. funding for COVID-19 tests

Private equity firm Carlyle Group Inc-backed Ortho Clinical Diagnostics said on Wednesday its COVID-19 antibody testing program received a grant of $678,000 from the U.S. Biomedical Advanced Research and Development Authority (BARDA).

Carlyle-backed ZoomInfo's shares soar 90% in U.S. market debut

Shares of ZoomInfo Technologies Inc almost doubled in their U.S. market debut on Thursday, after the business intelligence platform raised about $934.5 million in the largest U.S. technology listing so far this year.

Carlyle's Africa dealmakers leave to start their own buyout firm

Four dealmakers responsible for Carlyle Group Inc's <CG.O> Sub-Saharan Africa Fund are leaving to launch their own firm, Carlyle said on Wednesday, in the latest private equity retreat from the continent.

Carlyle's Africa dealmakers leave to start their own buyout firm

Four dealmakers responsible for Carlyle Group Inc's Sub-Saharan Africa Fund are leaving to launch their own firm, Carlyle said on Wednesday, in the latest private equity retreat from the continent.

CORRECTED-Carlyle, GIC’s cold feet on Amex travel buy casts doubt on US$1.1bn loan

A US$1.1bn leveraged loan partially supporting the Carlyle Group and Singaporean sovereign wealth fund GIC Pte Ltd’s purchase of a 20% stake in American Express Global Business Travel (Amex GBT) has been called into question as the investors look to walk away from the transaction...

BRIEF-Sequent Scientific Says Carlyle Group To Buy Stake In Co

* CARLYLE GROUP ENTERS AGREEMENTS TO BUY MAJORITY STAKE IN SEQUENT SCIENTIFIC LIMITED

Carlyle beats first-quarter profit estimates as distributable earnings surge

Carlyle Group Inc <CG.O> said on Thursday its first-quarter distributable earnings rose 73% year-on-year, beating Wall Street's expectations as asset sales in its private equity and credit investment divisions generated strong earnings ahead of the coronavirus-induced market...

Carlyle beats Q1 profit estimates as distributable earnings surge

Carlyle Group Inc said on Thursday that its first-quarter distributable earnings rose 73% year-on-year, beating Wall Street's expectations, as asset sales in its private equity and credit investment divisions generated strong performance fees ahead of the coronavirus-induced...

Carlyle raises $2.3 billion for its biggest Japan fund to date

Carlyle Group <CG.O> said it has raised 258 billion yen ($2.3 billion) for its biggest Japan fund to date, aiming to pick up businesses shed by conglomerates as well as companies where elderly owners have no obvious successors.

BRIEF-Carlyle completes acquisition of Harwood Wealth Management

* RECOMMENDED CASH ACQUISITION BY BIDCO OF HARWOOD HAS NOW BECOME EFFECTIVE

As coronavirus fears grow, private equity eyes distressed investments

Major private equity firms, which have built up big distressed debt funds in recent years, are ready to snap up assets on the cheap if the coronavirus outbreak causes deeper market disruptions, executives told an industry meeting this week.

As coronavirus fears grow, private equity eyes distressed investments

Major private equity firms, which have built up big distressed debt funds in recent years, are ready to snap up assets on the cheap if market disruptions continue, senior executives said at an industry meeting this week.

Blackstone, Carlyle make $17.5 billion bid for Thyssenkrupp elevator: sources

A consortium consisting of Blackstone <BX.N>, Carlyle <CG.O> and the Canada Pension Plan Investment Board has made a roughly 16 billion euro ($17.5 billion) bid for Thyssenkrupp's <TKAG.DE> elevator unit, two people familiar with the matter said.

Carlyle Group picks JP Morgan to sell Italy fashion brand Twinset: source

U.S. private equity Carlyle Group has mandated JP Morgan as financial consultant to sell Italian fashion brand Twinset, a source close to the matter said on Tuesday.

Carlyle looking at 'relatively cheap' energy assets: Rubenstein

Fears about the future of energy assets have led to a sell-off, but this has created "very good opportunities" for the Carlyle Group, its founder, David Rubenstein, said on Thursday.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up